Literature DB >> 22050548

Expression of the interleukin-10 signaling pathway genes in individuals with Down syndrome and periodontitis.

Lícia Bezerra Cavalcante1, Marcia Hiromi Tanaka, Juliana Rico Pires, Luciano Henrique Apponi, Elisa Maria Aparecida Giro, Sandro Roberto Valentini, Denise M Palomari Spolidório, Marisa Veiga Capela, Carlos Rossa, Raquel M Scarel-Caminaga.   

Abstract

BACKGROUND: Individuals with Down syndrome (DS) have a higher prevalence and severity of periodontal disease, which cannot be explained by poor oral hygiene alone and is related to changes in the immune response. The aim of this study is to evaluate whether DS was associated with differential modulation of expression of genes associated with proinflammatory and anti-inflammatory responses in periodontal disease.
METHODS: A total of 51 individuals were evaluated: 19 individuals with DS and periodontal disease (group 1), 20 euploid individuals with periodontal disease (group 2; positive control), and 12 euploid individuals without periodontal disease (group 3; negative control). Clinical periodontal evaluation and gingival biopsies were performed. Quantitative reverse transcription-polymerase chain reaction was used to determine expression levels of interleukin-10 (IL-10), the receptors IL-10RA and IL-10RB, intracellular adhesion molecule 1 (ICAM-1), interferon-γ-inducible protein 10 (IP-10), and the signaling intermediates Janus kinase 1, signal transducer and activator of transcription 3 (STAT-3), and suppressor of cytokine signaling 3 (SOCS-3).
RESULTS: Expression of IL10, SOCS3, IP10, and ICAM1 mRNA in DS patients was significantly lower compared to euploid individuals with periodontal disease, whereas IL-10RB and STAT-3 mRNA levels were higher in individuals with DS.
CONCLUSION: Reduced expression of IL-10 coupled with a possible increase of STAT3 activation (increase of STAT3 and reduction of SOCS3 mRNA) indicates an important modulation of the immune response, with attenuation of anti-inflammatory and increase of proinflammatory mediators. This modulation may be related to the increased prevalence and severity of periodontitis in individuals with DS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050548     DOI: 10.1902/jop.2011.110056

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  10 in total

1.  The effect of conventional mechanical periodontal treatment on red complex microorganisms and clinical parameters in Down syndrome periodontitis patients: a pilot study.

Authors:  M H Tanaka; T O Rodrigues; L S Finoti; S R L Teixeira; M P A Mayer; R M Scarel-Caminaga; E M A Giro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-04       Impact factor: 3.267

2.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

Review 3.  Prevention and Periodontal Treatment in Down Syndrome Patients: A Systematic Review.

Authors:  Rafael Ferreira; Raphaella Coelho Michel; Sebastião Luiz Aguiar Greghi; Maria Lúcia Rubo de Resende; Adriana Campos Passanezi Sant'Ana; Carla Andreotti Damante; Mariana Schutzer Ragghianti Zangrando
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

4.  Porphyromonas gingivalis and its lipopolysaccharide differently modulate epidermal growth factor-dependent signaling in human gingival epithelial cells.

Authors:  R Elkaim; I M Bugueno-Valdebenito; N Benkirane-Jessel; H Tenenbaum
Journal:  J Oral Microbiol       Date:  2017-06-15       Impact factor: 5.474

5.  Dyslipidemia rather than Type 2 Diabetes Mellitus or Chronic Periodontitis Affects the Systemic Expression of Pro- and Anti-Inflammatory Genes.

Authors:  Rafael Nepomuceno; Bárbara Scoralick Villela; Sâmia Cruz Tfaile Corbi; Alliny De Souza Bastos; Raquel Alves Dos Santos; Catarina Satie Takahashi; Silvana Regina Perez Orrico; Raquel Mantuaneli Scarel-Caminaga
Journal:  Mediators Inflamm       Date:  2017-02-20       Impact factor: 4.711

6.  Differential Expression of Inflammation-Related Genes in Down Syndrome Patients with or without Periodontal Disease.

Authors:  M Baus-Domínguez; R Gómez-Díaz; D Torres-Lagares; J R Corcuera-Flores; J C Ruiz-Villandiego; G Machuca-Portillo; J L Gutiérrez-Pérez; M A Serrera-Figallo
Journal:  Mediators Inflamm       Date:  2019-10-21       Impact factor: 4.711

7.  Susceptibility to Heart Defects in Down Syndrome Is Associated with Single Nucleotide Polymorphisms in HAS 21 Interferon Receptor Cluster and VEGFA Genes.

Authors:  Carmela Rita Balistreri; Claudia Leonarda Ammoscato; Letizia Scola; Tiziana Fragapane; Rosa Maria Giarratana; Domenico Lio; Maria Piccione
Journal:  Genes (Basel)       Date:  2020-11-28       Impact factor: 4.096

8.  Identification of Neuropeptides as Potential Crosstalks Linking Down Syndrome and Periodontitis Revealed by Transcriptomic Analyses.

Authors:  Yue Chen; Xiaofei Yu; Jia Kong
Journal:  Dis Markers       Date:  2021-09-10       Impact factor: 3.434

9.  Interleukin-10 polymorphisms affect the key periodontal pathogens in Chinese periodontitis patients.

Authors:  Ying Geng; Lu Li; Xiaoqian Wang; Fanzhen He; Yi Zhou; Mifang Yang; Yan Xu
Journal:  Sci Rep       Date:  2018-06-13       Impact factor: 4.379

10.  Inhibitory designer receptors aggravate memory loss in a mouse model of down syndrome.

Authors:  Eric D Hamlett; Aurélie Ledreux; Anah Gilmore; Elena M Vazey; Gary Aston-Jones; Heather A Boger; Daniel Paredes; Ann-Charlotte E Granholm
Journal:  Neurobiol Dis       Date:  2019-10-31       Impact factor: 5.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.